Teva UK launches three new products

Teva has announced the UK launch of three new generic products, further expanding its market-leading portfolio.

Its generic carbocisteine capsules and mometasone nasal spray PL00289-1748 were made available to order on January 2nd 2014 and come packaged in the Teva 360 livery.

These two launches were followed immediately on January 3rd by the introduction of generic carmellose (Carmize) eye drops, which are sold in Aspire's livery with Teva barcodes. Users can select between eye drops or ophthalmic solution options.

Kim Innes, commercial director at Teva UK, said the company was delighted to be able to add these new products to its portfolio, stating that this "demonstrates our ongoing commitment to pharmacy".

Teva is one of the UK's top ten pharmaceutical manufacturers and boasts the widest range of any generic pharmaceutical company in Britain.

Last month, the firm was awarded with a Silver Quality Mark from the government, via the Workplace Giving UK programme, in recognition of the charitable donations it makes as an organisation.